Sanofi, Janssen partner on potential E. coli pathogenic vaccine

By NS Healthcare Staff Writer

04 Oct 23

According to the agreement, both firms will co-fund current and future research and development expenditures with Sanofi paying…

PharmaceuticalsPartnerships and Licensing Agreements

Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration

By NS Healthcare Staff Writer

03 Oct 23

Refinancing of Current $400M Debt at Lower Cost and Improved Amortization Schedule

PharmaceuticalsPartnerships and Licensing Agreements

IAMA Therapeutics Announces Multi-Phase, Strategic Provider Agreement with Evotec

By NS Healthcare Staff Writer

03 Oct 23

The agreement expands the companies' existing relationship, which entails collaborating on IND-enabling preclinical studies for IAMA-6

PharmaceuticalsPartnerships and Licensing Agreements

Ionis, Roche partner for two RNA-targeted programmes to treat AD and HD

By NS Healthcare Staff Writer

28 Sep 23

The Swiss pharmaceutical firm will obtain exclusive global rights to develop, manufacture, and market the medicines by making…

PharmaceuticalsPartnerships and Licensing Agreements

Novo Nordisk, Valo partner to develop new treatments for cardiometabolic diseases

By NS Healthcare Staff Writer

26 Sep 23

Valo will receive an upfront payment and a potential near-term milestone payment, totalling $60m, and is eligible to…

PharmaceuticalsPartnerships and Licensing Agreements

ICR, Merck extend partnership for small-molecule drugs to treat cancer

By NS Healthcare Staff Writer

25 Sep 23

Under the expanded partnership, scientists at the ICR’s Centre for Cancer Drug Discovery will work with researchers at…

PharmaceuticalsPartnerships and Licensing Agreements

JURA Bio Announces Partnership With Replay Product Company Syena to Advance T Cell Receptor NK Therapies in Cancer

By NS Healthcare Staff Writer

22 Sep 23

Collaboration leverages JURA Bio’s T cell receptor (TCR) discovery platform to discover and develop innovative therapies by applying…

PharmaceuticalsPartnerships and Licensing Agreements

Kezar, Everest partner to develop and market zetomipzomib in Asian markets

By NS Healthcare Staff Writer

21 Sep 23

Everest will obtain exclusive rights to develop and commercialise zetomipzomib in Greater China, South Korea, and other South…

PharmaceuticalsPartnerships and Licensing Agreements

RefleXion licenses 3BP’s RXM-4768 molecule for unmet cancer needs

By NS Healthcare Staff Writer

21 Sep 23

Under the licensing agreement, RefleXion will develop and commercialise RXM-4768 molecule to direct its SCINTIX biology-guided radiotherapy

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Orionis signs molecular glue class medicines deal with Genentech

By NS Healthcare Staff Writer

21 Sep 23

Under the partnership, both parties will discover novel small molecule drugs using Orionis’s Allo-Glue platform for challenging targets…

PharmaceuticalsPartnerships and Licensing Agreements